Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24126646 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure
Condition: Hepatitis
Intervention: Device: Molecular Adsorbent Recirculating System (MARS®)

Indicates status has not been verified in more than two years